Matches in Wikidata for { <http://www.wikidata.org/entity/Q37150064> ?p ?o ?g. }
- Q37150064 description "2008 nî lūn-bûn" @default.
- Q37150064 description "2008年の論文" @default.
- Q37150064 description "2008年学术文章" @default.
- Q37150064 description "2008年学术文章" @default.
- Q37150064 description "2008年学术文章" @default.
- Q37150064 description "2008年学术文章" @default.
- Q37150064 description "2008年学术文章" @default.
- Q37150064 description "2008年學術文章" @default.
- Q37150064 description "2008年學術文章" @default.
- Q37150064 description "2008年學術文章" @default.
- Q37150064 description "2008年學術文章" @default.
- Q37150064 description "2008年學術文章" @default.
- Q37150064 description "2008年學術文章" @default.
- Q37150064 description "2008년 논문" @default.
- Q37150064 description "article científic" @default.
- Q37150064 description "article scientific" @default.
- Q37150064 description "article scientifique publié en 2008" @default.
- Q37150064 description "articol științific" @default.
- Q37150064 description "articolo scientifico" @default.
- Q37150064 description "artigo científico (publicado na 2008)" @default.
- Q37150064 description "artigo científico (publicado na 2008)" @default.
- Q37150064 description "artigo científico" @default.
- Q37150064 description "artikull shkencor" @default.
- Q37150064 description "artikulong pang-agham" @default.
- Q37150064 description "artykuł naukowy" @default.
- Q37150064 description "artículo científico publicado en 2008" @default.
- Q37150064 description "artículu científicu espublizáu en 2008" @default.
- Q37150064 description "bilimsel makale" @default.
- Q37150064 description "bài báo khoa học" @default.
- Q37150064 description "mokslinis straipsnis" @default.
- Q37150064 description "naučni članak" @default.
- Q37150064 description "scienca artikolo" @default.
- Q37150064 description "scientific article published on 29 April 2008" @default.
- Q37150064 description "teaduslik artikkel" @default.
- Q37150064 description "tieteellinen artikkeli" @default.
- Q37150064 description "tudományos cikk" @default.
- Q37150064 description "vedecký článok" @default.
- Q37150064 description "vetenskaplig artikel" @default.
- Q37150064 description "videnskabelig artikel (udgivet 2008)" @default.
- Q37150064 description "vitenskapelig artikkel" @default.
- Q37150064 description "vitskapeleg artikkel" @default.
- Q37150064 description "vědecký článek" @default.
- Q37150064 description "wetenschappelijk artikel" @default.
- Q37150064 description "wissenschaftlicher Artikel" @default.
- Q37150064 description "επιστημονικό άρθρο" @default.
- Q37150064 description "мақолаи илмӣ" @default.
- Q37150064 description "мақолаи илмӣ" @default.
- Q37150064 description "наукова стаття, опублікована у квітні 2008" @default.
- Q37150064 description "научна статия" @default.
- Q37150064 description "научная статья" @default.
- Q37150064 description "научни чланак" @default.
- Q37150064 description "научни чланак" @default.
- Q37150064 description "գիտական հոդված" @default.
- Q37150064 description "מאמר מדעי" @default.
- Q37150064 description "سائنسی مضمون" @default.
- Q37150064 description "مقالة علمية نشرت في 29 أبريل 2008" @default.
- Q37150064 description "مقالهٔ علمی" @default.
- Q37150064 description "২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q37150064 description "บทความทางวิทยาศาสตร์" @default.
- Q37150064 description "სამეცნიერო სტატია" @default.
- Q37150064 name "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 name "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 name "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 type Item @default.
- Q37150064 label "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 label "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 label "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 prefLabel "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 prefLabel "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 prefLabel "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 P1433 Q37150064-8EC933D9-210D-4C5D-A46F-6DD96AB346B9 @default.
- Q37150064 P1476 Q37150064-CAB3EE55-555E-4284-BDDB-25BE85EA5B05 @default.
- Q37150064 P2093 Q37150064-5B873839-5EF3-4C87-96F3-4B8402480925 @default.
- Q37150064 P2093 Q37150064-6377B9FA-2630-4BD2-8DD3-9F9F0DF906C5 @default.
- Q37150064 P2093 Q37150064-6B5267D2-BDF8-4CB8-8F67-59C6CDFF6824 @default.
- Q37150064 P2093 Q37150064-87884DBA-3DC9-48DB-A84E-8AEF40550145 @default.
- Q37150064 P2093 Q37150064-883DF779-A5DB-4B7F-B913-B6479D6FC8F7 @default.
- Q37150064 P2093 Q37150064-B1DE3EAE-40CB-44B1-95CB-8BCBCD2E59AE @default.
- Q37150064 P2093 Q37150064-D4B53299-0AEB-4F19-82EC-B85BFA7E92E4 @default.
- Q37150064 P2860 Q37150064-54A01A0E-A6EE-468B-9A87-BB41782692C8 @default.
- Q37150064 P2888 Q37150064-ADFD6969-DD04-4B26-88FA-6BE82A76D7A8 @default.
- Q37150064 P304 Q37150064-92109252-5C0A-44B5-B63B-40BB24E0E319 @default.
- Q37150064 P31 Q37150064-390F5F61-27E9-4DE8-8C6A-E0700AE20BE6 @default.
- Q37150064 P356 Q37150064-BD9B1784-9822-4334-8A9E-F0B5BC9716BD @default.
- Q37150064 P407 Q37150064-4D943A79-BA4F-42C4-B8D9-50D07F515FC6 @default.
- Q37150064 P433 Q37150064-271932C5-5D46-496A-BE17-A052AA48F2A5 @default.
- Q37150064 P478 Q37150064-31CBCEB0-45DF-440B-931A-842E75EBF7FA @default.
- Q37150064 P577 Q37150064-C4F6DA52-5660-431D-A2F5-6FACEC7C0B17 @default.
- Q37150064 P698 Q37150064-3390B0D4-BE87-49EE-B1D4-296ADDC2E3C8 @default.
- Q37150064 P921 Q37150064-2156BBEE-D366-46E6-9552-7C448B456A39 @default.
- Q37150064 P921 Q37150064-5CF1FD64-9F27-4035-A7C2-6C1B49E626E8 @default.
- Q37150064 P921 Q37150064-74B018B7-9CDE-4C3A-B9A0-6828597D9224 @default.
- Q37150064 P356 S10549-008-0034-1 @default.
- Q37150064 P698 18443903 @default.
- Q37150064 P1433 Q326085 @default.
- Q37150064 P1476 "Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects" @default.
- Q37150064 P2093 "Heather-Jane Au" @default.
- Q37150064 P2093 "Kamran Golmohammadi" @default.
- Q37150064 P2093 "Konrad Fassbender" @default.
- Q37150064 P2093 "Philip Jacobs" @default.